Skip to main content
. 2018 Nov 27;9(3):526–536. doi: 10.1016/j.apsb.2018.11.004

Figure 2.

Fig. 2

OCA treatment alleviates CCl4-induced HSCs activation and liver fibrosis. (A) Serum ALT and AST levels. (B)–(E) Histological analysis of liver sections. H&E staining (B), Masson staining (C), Sirius Red staining (D) and immunohistochemistry of α-SMA (E). (F) Expression profiling of fibrosis-related genes. Results are mean ± SD (n = 5), *P < 0.05, **P < 0.01, ***P < 0.001, #P < 0.05, ##P < 0.01.